Five things for pharma marketers to know: Thursday, April 27, 2017

Novartis, Kaiser, and Qualcomm partner on heart-failure pilot; Novartis and GSK disclose DTC plans; cancer-treatment hype can be negative for patients

A new tool seeks to educate docs about Parkinson's symptoms

The device could be used by physicians to better understand the severity of a patient's symptoms and elicit empathy.

Amgen, Sandoz argue biosimilar patent case to the Supreme Court

Amgen, Sandoz argue biosimilar patent case to the Supreme Court

Sandoz counsel argued that Amgen's position "wrongly delays the marketing of every biosimilar."

MedImmune goes after challenging lupus market

MedImmune goes after challenging lupus market

While investments in investigational lupus agents appear to be heating up, late-stage clinical failure continues to be a major hurdle to market entry.

Top 25 autoimmune brands in 2016, based on U.S. sales

Top 25 autoimmune brands in 2016, based on U.S. sales

AbbVie's Humira tops the list, according to data compiled by EvaluatePharma.

Five things for pharma marketers to know: Wednesday, April 26, 2017

Five things for pharma marketers to know: Wednesday, April 26, 2017

GSK warns Advair generic competition may affect business in 2017; Lilly plans to meet FDA about baricitinib; FDA warns companies selling 'illegal' products

Drugmakers battle for slice of Humira's billions

Drugmakers battle for slice of Humira's billions

Makers of biosimilars have targeted a few of the top-selling autoimmune drugs. Get ready for some of the highest-stakes pricing and access skirmishes in recent pharma history.

Study: Medical-marijuana laws lower prescription drug usage

Study: Medical-marijuana laws lower prescription drug usage

The research found a reduction in utilization of medications used to treat depression, nausea, and psychosis when looking at data for Medicaid beneficiaries.

Five things for pharma marketers to know: Tuesday, April 25, 2017

Five things for pharma marketers to know: Tuesday, April 25, 2017

Sanofi sues Mylan over anticompetitive practices; Anthem to drop Express Scripts; GSK chief digital officer says advertisers should focus on fewer publishers

Read the complete April 2017 digital edition

Read the complete April 2017 digital edition

Here you'll find everything you need to know from MM&M's April 2017 issue, including our DTC report, our deep dive into respiratory drugs, and more.

PerfectLens sees ROI with programmatic ad buying

PerfectLens sees ROI with programmatic ad buying

The Canadian contact lens etailer partnered with a new technology vendor to look beyond its direct click-to-conversions.

Five things for pharma marketers to know: Monday, April 24, 2017

Five things for pharma marketers to know: Monday, April 24, 2017

QuintilesIMS partners with Salesforce; the E.U. to decide on new EMA location by June; drugmakers boost lobbying dollars in Q1

Purdue Pharma hires new VP of public affairs, communications

Purdue Pharma hires new VP of public affairs, communications

Josephine Martin was previously EVP of public affairs at PhRMA.

Five things for pharma marketers to know: Friday, April 21, 2017

Five things for pharma marketers to know: Friday, April 21, 2017

Teva launches branded competitor to GSK's Advair; Valeant prices psoriasis drug at $3,500 per month; overseas drug importation would save money, op-ed argues

Five things for pharma marketers to know: Thursday, April 20, 2017

Five things for pharma marketers to know: Thursday, April 20, 2017

Tesaro discloses price for new drug that differs from FDA-approved dosage; uniQure discontinues Glybera; O'Reilly leaves Fox

Pharma R&D partnerships are on the rise: report

Pharma R&D partnerships are on the rise: report

This is likely due, in part, to the increasingly complex nature of new specialty drugs.

PhRMA debuts new ads in Go Boldly campaign

PhRMA debuts new ads in Go Boldly campaign

PhRMA worked with WPP Health & Wellness and Young & Rubicam on creative for the ads.

Five things for pharma marketers to know: Wednesday, April 19, 2017

Five things for pharma marketers to know: Wednesday, April 19, 2017

Valeant gave $100,000 to patient group to address affordability of its drug; Omnicom reports 3% increase in specialty group revenue; Verily to study biometric data

In Merck video, woman says a cure is the greatest invention

In Merck video, woman says a cure is the greatest invention

The drugmaker's video asks people in New York and San Francisco about their ideas for great inventions.

J&J blames lower Xarelto and Invokana sales on payer pressure

J&J blames lower Xarelto and Invokana sales on payer pressure

The drugmaker said it has been forced to provide higher rebates to PBMs and insurers for certain drugs.

Agency Spotlight

Featured Listings

OPINION

Newsletters